| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 27, 1690-1697, Copyright © 1981 by American Association for Clinical Chemistry
T Nishino, T Kodaira, S Shin, K Imagawa, K Shima, Y Kumahara, C Yanaihara and N Yanaihara
In this pancreatic-glucagon-specific radioimmunoassay we used C- terminal-region-specific antiserum. OAL-123, produced against a 19-29 C- terminal fragment of porcine glucagon. On measurement of pooled plasma the ranges for intra- and inter-assay coefficients of variation were 4.8-8.1% and 7.5-10.7%, respectively. The concentration of immunoreactive glucagon in plasma of healthy subjects, as measured with the OAL-123 assay system, was 87.9 (SD 23.8) ng/L. Measurement of the same plasma samples with the 30K assay system (30K being an antiserum highly specific for pancreatic glucagon) showed a comparable value, 86.2 (SD 26.3) ng/L. We followed changes in human and dog plasma immunoreactive glucagon concentrations on arginine infusion and after glucose load, using the OAL-123 and the 30K assay systems, with identical results. Combining other results of comparative immunochemical characterization of the OAL-123 and 30K assay systems, we confirmed that the antisera raised against the C-terminal fragment of glucagon can be used in radioimmunoassay of pancreatic glucagon.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  X.-Q. Chen, J. Dong, C.-Y. Niu, J.-M. Fan, and J.-Z. Du Effects of Hypoxia on Glucose, Insulin, Glucagon, and Modulation by Corticotropin-Releasing Factor Receptor Type 1 in the Rat Endocrinology, July 1, 2007; 148(7): 3271 - 3278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chang, H. Hanawa, H. Liu, T. Yoshida, M. Hayashi, R. Watanabe, S. Abe, K. Toba, K. Yoshida, R. Elnaggar, et al. Hydrodynamic-Based Delivery of an Interleukin-22-Ig Fusion Gene Ameliorates Experimental Autoimmune Myocarditis in Rats J. Immunol., September 15, 2006; 177(6): 3635 - 3643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Montero, H. Mendoza, V. Valles, M. Lemus, R. Alvarez-Buylla, and E. R. de Alvarez-Buylla Arginine-vasopressin mediates central and peripheral glucose regulation in response to carotid body receptor stimulation with Na-cyanide J Appl Physiol, June 1, 2006; 100(6): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, H. Hanawa, T. Yoshida, R. Elnaggar, M. Hayashi, R. Watanabe, K. Toba, K. Yoshida, H. Chang, Y. Okura, et al. Effect of Hydrodynamics-Based Gene Delivery of Plasmid DNA Encoding Interleukin-1 Receptor Antagonist-Ig for Treatment of Rat Autoimmune Myocarditis: Possible Mechanism for Lymphocytes and Noncardiac Cells Circulation, April 5, 2005; 111(13): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W Persky, M. E Turyk, L. Wang, S. Freels, R. Chatterton Jr, S. Barnes, J. Erdman Jr, D. W Sepkovic, H L. Bradlow, and S. Potter Effect of soy protein on endogenous hormones in postmenopausal women Am. J. Clinical Nutrition, January 1, 2002; 75(1): 145 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mizuno, T. Murakami, S. Otani, M. Kuwajima, and K. Shima Leptin Affects Pancreatic Endocrine Functions through the Sympathetic Nervous System Endocrinology, September 1, 1998; 139(9): 3863 - 3870. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
